Total Funding
64
46
Total FundingPost-IPO Equity raised
Growth Score
-20 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
101777
ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.
- Sang Hoon Lee: CEOPast Role: Genentech, Scientist/Group Leader
- Jaecheon Jerry: CFO & Vice PresidentPast Role: Oliver Wyman, Associate Consultant
About the Company
ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Their core values are life-improvement, collaboration, innovation, and novel therapy.
